LEAP is a Blood Test to Help
Screen for Lung Cancer
Lung cancer is the leading cause of cancer death in the U.S.
In 2026 more women will die of lung cancer (61,950) than breast cancer (42,120)
More men will die of lung cancer (63,040) than prostate cancer (36,320)**
Lung cancer is projected to kill approximately 125,000 Americans in 2026—more than colorectal and pancreatic cancers combined. About 15 million adults are eligible for annual lung cancer screening but fewer than one in five actually receive it.
Millions remain unscreened, and precious opportunities to detect lung cancer while it may still be curable are lost.
Closing this screening gap is an urgent public health priority.
LEAP was developed to improve access to lung cancer screening and eliminate thousands of avoidable deaths every year.
It’s a simple blood test that helps physicians identify higher-risk individuals who may need specialized testing, including a low-dose CT chest scan.
LEAP measures the systemic activity of proteases—enzymes involved in how cancer interacts with surrounding tissue and the immune system—to identify the biological changes associated with lung cancer at its earliest stages, when it is most treatable.
** American Cancer Society estimates 2026
How LEAP works:
Ordering the LEAP test
If you would like to order the LEAP test or if you simply need more information please contact us by clicking the button below.
Who should get LEAP? LEAP is for individuals between the ages of 50 and 80 who have smoked at least a pack a day for 20 years, and who currently smoke or quit within the last 15 years.
What will the LEAP results mean? LEAP will report a NORMAL or ABNORMAL result. A NORMAL result indicates the test returned an enzyme profile that looks like someone who does not have lung cancer. An ABNORMAL result refers to a blood enzyme profile similar to that seen in patients who have confirmed lung cancer.
Where is LEAP manufactured? LEAP is manufactured in California to the highest quality standards and runs at HealthQuest Esoterics, Inc., a leading full-service licensed medical reference laboratory. Results are typically available 7 days after sample receipt.
For more information, please contact us at: info@hawkeyebio.com or click the button below.
LEAP is a lab-developed test (LDT), which means it is regulated under a program called CLIA and runs is specially authorized labs. It has not been cleared or approved by the FDA.
A safe and easy test that requires only a standard blood draw (1 tube)
Delivers a fast and actionable results in 7 days or less
Identifies cancer signature by detecting abnormal enzyme activity
Highly sensitive (95%); 99.9% negative predictive value, clinically validated.